Análise das coletas de citologias oncóticas realizadas na atenção primária à saúde

Abstract

Cervical Cancer (CC) has been killing many women every year, even though it is a slowly progressing neoplasm, which can act locally or in distant locations, in the human body. The main means of prevention is the oncotic cytology test, available in primary care, through the SUS. This work aimed to analyze data on cancer cytology in primary care. Cancer has non-specific causes, however, with multiple risk factors, it can be local or systemic, it has treatment and, in many cases, the possibility of a cure. Among the different types of cancer we have CC, this neoplasm has several risk factors, the main one being HPV infection, 90% of its lesions appear in the Transition Zone (TZ) and its prevention occurs, mainly with the oncotic cytology exam. and the HPV vaccine, both of which are made available by the SUS. This is a descriptive quantitative study, with data collected from Siscan and the Mortality Atlas. It was found that 44% of oncotic cytology collections carried out in 2022 were without ZT and in 2023, until the month of October, the number of unsatisfactory collections reached 83.31% of the value for the year 2022. Between 2020 and 2021, 13,233 deaths from CC were recorded. Therefore, the study showed that there is a similarity between the number of deaths due to CC and collection failures, making it possible to see that they, at times, grow together, emphasizing the importance of ongoing education among professionals.